Arno Schad
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Drug Transport and Resistance Mechanisms
- Cancer Research top 5%
Papers in
- Oncology 40
- Drug Transport and Resistance Mechanisms 8
- Cancer-related Molecular Pathways 7
-
- Peroxisome Proliferator-Activated Receptors 10
- Co-authors
- Thomas J. Musholt (18 shared papers)Peter R. Galle (22 shared papers)Alfred Völkl (8 shared papers)Gerhard Fritz (5 shared papers)Eveline Baumgart‐Vogt (8 shared papers)Christian Fottner (11 shared papers)H. Dariush Fahimi (6 shared papers)Matthias M. Weber (10 shared papers)
- Journals
- BMC Cancer (4 papers)Langenbeck s Archives of Surgery (3 papers)World Journal of Surgery (3 papers)Histochemistry and Cell Biology (3 papers)Cancers (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Arno Schad
92 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 119
- Oncology 835
- Cancer Research 369
- Biochemistry 160
- Hepatology 140
- Molecular Biology 1.1k
Countries citing papers authored by Arno Schad
This map shows the geographic impact of Arno Schad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arno Schad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arno Schad more than expected).
Fields of papers citing papers by Arno Schad
This network shows the impact of papers produced by Arno Schad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arno Schad. The network helps show where Arno Schad may publish in the future.
Co-authors
The 25 scholars most cited alongside Arno Schad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 142 | |
| 2 | 2008 | 111 | |
| 3 | 2009 | 92 | |
| 4 | 2009 | 89 | |
| 5 | 2004 | 88 | |
| 6 | 2012 | 87 | |
| 7 | 2011 | 81 | |
| 8 | 2013 | 81 | |
| 9 | 2005 | 74 | |
| 10 | 2020 | 66 | |
| 11 | 2014 | 65 | |
| 12 | 2007 | 62 | |
| 13 | 2010 | 58 | |
| 14 | 2010 | 57 | |
| 15 | 2019 | 56 | |
| 16 | 2012 | 52 | |
| 17 | 2002 | 49 | |
| 18 | 2003 | 46 | |
| 19 | 2003 | 46 | |
| 20 | 2014 | 44 |
About Arno Schad
Arno Schad is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Surgery, having authored 94 papers that have together received 2.6k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (10 papers), Peroxisome Proliferator-Activated Receptors (10 papers), Neuroendocrine Tumor Research Advances (10 papers), Drug Transport and Resistance Mechanisms (8 papers), Cancer-related Molecular Pathways (7 papers), Lung Cancer Treatments and Mutations (7 papers), Genetic factors in colorectal cancer (6 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Oncology (835 citations), Cancer Research (369 citations), Biochemistry (160 citations), Hepatology (140 citations) and Molecular Biology (1.1k citations). Arno Schad has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Thomas J. Musholt, Peter R. Galle, Alfred Völkl, Gerhard Fritz, Eveline Baumgart‐Vogt, Christian Fottner, H. Dariush Fahimi, Matthias M. Weber, Karl J. Lackner and Hauke Lang. Their work appears in journals such as BMC Cancer, Langenbeck s Archives of Surgery, World Journal of Surgery, Histochemistry and Cell Biology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.